📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Safety and immunogenicity of ChAdOx1 85A prime followed by MVA85A boost compared with BCG revaccination among Ugandan adolescents who received BCG at birth: a randomised, open-label trial. (2024)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s1473-3099(23)00501-7

PubMed Identifier: 38012890

Publication URI: http://europepmc.org/abstract/MED/38012890

Type: Journal Article/Review

Volume: 24

Parent Publication: The Lancet. Infectious diseases

Issue: 3

ISSN: 1473-3099